Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Mayoh

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Neuro-Oncology|March 12, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patientsMarion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in NeuroblastomaLin Xiao, Klaartje Somers, Jayne Murray, et al.
Nature Communications|December 12, 2024
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastomaJourdin R C Rouaen, Antonietta Salerno, Tyler Shai-Hee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Oncogene|January 24, 2019
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunctionKlaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Nature Communications|November 7, 2019
The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35Pei Y Liu, Andrew E Tee, Giorgio Milazzo, et al.
Science Translational Medicine|February 1, 2019
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaLaura D Gamble, Stefania Purgato, Jayne Murray, et al.
Cancer Research|July 31, 2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk CancerChelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Neuro-Oncology|March 12, 2025
Germline analysis of an international cohort of pediatric diffuse midline glioma patientsMarion K Mateos, Pamela Ajuyah, Noemi Fuentes-Bolanos, et al.
Molecular Cancer Therapeutics|April 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the YoungAshleigh M Fordham, Lauren M Brown, Chelsea Mayoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in NeuroblastomaLin Xiao, Klaartje Somers, Jayne Murray, et al.
Nature Communications|December 12, 2024
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastomaJourdin R C Rouaen, Antonietta Salerno, Tyler Shai-Hee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination TherapyJingwei Chen, Christopher Nelson, Matthew Wong, et al.
Oncogene|January 24, 2019
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunctionKlaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, et al.
Pageof 10